In Thursday’s Wall Street session, ITeos Therapeutics Inc (NASDAQ:ITOS) shares traded at $7.97, up 4.87% from the previous session.
ITOS stock price is now 19.36% away from the 50-day moving average and -14.17% away from the 200-day moving average. The market capitalization of the company currently stands at $305.04M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target maintained at $9, Leerink Partners recently Downgraded its rating from Outperform to Market Perform for ITeos Therapeutics Inc (NASDAQ: ITOS). , while ‘JP Morgan’ rates the stock as ‘Neutral’
In other news, GADICKE ANSBERT, Former 10% Owner sold 1,031,931 shares of the company’s stock on May 13 ’25. The stock was sold for $8,317,364 at an average price of $8.06. Upon completion of the transaction, the Former 10% Owner now directly owns 3,452,797 shares in the company, valued at $27.52 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 13 ’25, Former 10% Owner MPM BIOVENTURES 2018, L.P. sold 630,191 shares of the business’s stock. A total of $5,079,339 was realized by selling the stock at an average price of $8.06. This leaves the insider owning 2,108,594 shares of the company worth $16.81 million. A total of 13.52% of the company’s stock is owned by insiders.
During the past 12 months, ITeos Therapeutics Inc has had a low of $4.80 and a high of $18.70. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 14.13, and a quick ratio of 14.13.
The net profit margin was -373.75% and return on equity was -23.68% for ITOS.
